• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$38.64 $0.13 (0.34%)

REAL-TIME: Last trade at

BioMarin Pharmaceutical

NASDAQ:BMRN

Jump to this page for:

Related Resources

8 Biotechnology Stocks With Good Liquidity That Analysts Rate As Buy

5/25/2012 by Seeking Alpha

Myriad Inks Deal with Cephalon - Analyst Blog

4/2/2012 by Nasdaq

This Just In: Upgrades and Downgrades

3/27/2012 by DailyFinance

BioMarin Raised to Neutral - Analyst Blog

3/14/2012 by Nasdaq

Make Money in Growing Small Caps -- the Easy Way

3/12/2012 by DailyFinance

Loss at BioMarin Wider Than Expected - Analyst Blog

2/17/2012 by Nasdaq

BioMarin Lowered to Underperform - Analyst Blog

2/15/2012 by Nasdaq

BioMarin Pharmaceutical (BMRN) - Bear of the Day

2/14/2012 by Nasdaq

Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone

2/14/2012 by Nasdaq

Zacks #5 Rank Additions for Wednesday - Tale of the Tape

2/8/2012 by Nasdaq

Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings

2/3/2012 by DailyFinance

Qiagen Expands with New Deals - Analyst Blog

1/12/2012 by Nasdaq

JPMorgan Confab Kicks Off Biotech 2012

1/5/2012 by Minyanville

Too Early for a New Biotech Orphan?

12/29/2011 by DailyFinance

BioMarin's Facility Expansion Backed - Analyst Blog

12/22/2011 by Nasdaq

As the Biotech Saying Goes...

12/7/2011 by DailyFinance

Pipeline Progress at BioMarin - Analyst Blog

12/1/2011 by Nasdaq

Facility Expansion at BioMarin - Analyst Blog

11/29/2011 by Nasdaq

Should You Get Out of BioMarin Pharmaceutical Before Next Quarter?

10/18/2011 by DailyFinance

The 8 Highest Potential Returns in Biotechnology

10/17/2011 by DailyFinance

Shire Enters a Crowded Market

8/31/2011 by DailyFinance

Give Avanir Some Time

8/9/2011 by DailyFinance

BioMarin Pharma Buys Irish Biologics Plant From Pfizer For $48.5 Million

6/23/2011 by Smart Money

The Significance of Raptor's Decision to Start With Orphan Disease Strategy

5/18/2011 by Minyanville

Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector

5/9/2011 by Seeking Alpha

A Dedication to R&D Means These Stocks Could See Robust Growth

4/25/2011 by Seeking Alpha

Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11)

4/10/2011 by Seeking Alpha

8 Promising Biotech Buyout Targets if Their Products Can Deliver

4/8/2011 by Seeking Alpha

4 Biotech Companies That Could Be Buyout Targets

4/5/2011 by Seeking Alpha

A Look at Citi Investment Research's Top Mid Cap Buy Recommendations

4/4/2011 by Seeking Alpha

Top 24 Most Oversold Takeover/LBO Targets

3/23/2011 by Seeking Alpha

30 Takeover Targets With Decreasing Short Interest

3/7/2011 by Seeking Alpha

UPDATE: BioMarin: Sanofi Says Genzyme Deal Isn't Control Change

2/25/2011 by Smart Money

2nd UPDATE: BioMarin: Sanofi Says Genzyme Buy Isn't Control Change

2/25/2011 by Smart Money

Sanofi Deal Brings Risk, Opportunity To Genzyme Partners

2/16/2011 by Smart Money

Do Mergers Mean Billions for Biotech?

2/16/2011 by Seeking Alpha

Do Mergers Means Billions for Biotech?

2/16/2011 by Seeking Alpha

U.S. Pharma: Latest Analyst Actions

12/5/2010 by Seeking Alpha

Analyst Calls: ATH, ANDE, BLK, BUCY, ITRI, LEAP, LM, PFG, SF, STP ...

12/2/2010 by BloggingStocks

Wednesday's High Volume Gainers With Bullish Options Sentiment

11/11/2010 by Seeking Alpha
See More Articles...